Citi, acting through Citibank N.A., has been appointed by Amryt Pharma Plc (“Amryt”) – a global, commercial-stage biopharmaceutical company dedicated to commercializing and developing novel therapeutics to treat patients suffering from serious and life-threatening rare diseases – to act as depositary bank for its American Depositary Receipt (“ADR”) programme. Amryt’s American Depositary Shares (“ADS”) trade on the Nasdaq Global Select market under the symbol “AMYT”. Each ADS represents five ordinary shares of the company. Amryt’s...
